Table 2.
Baseline characteristics and clinical data of participants who entered the Flo trial
‘Florence’ + TAU | TAU | t-test | |
---|---|---|---|
(N = 37) | (N = 28) | (Df = 62/63) | |
Gender female, n (%) | 19 (51) | 15 (54) | – |
Age, mean years (sd) | 36.2 (11.4) | 33.9 (10.9) | n.s. |
Duration of illness, mean years (sd) | 16.3 (11.3) | 12.1 (9.2) | n.s. |
Age leaving education mean age (sd) | 24.4 (18.7) | 28.1 (25.3) | n.s. |
Number of previous hospitalisations, mean number (sd) | 2.6 (2.5) | 2.3 (2.6) | n.s |
n.s. not significant; sd Standard deviation; TAU Treatment as usual